Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 969 - 976 of 11439 results
Why Would Anyone Want To Be A Law Firm Managing Partner?
July 3, 2023| News
Mintz's Chairman, R. Robert Popeo, Dies At 85
July 3, 2023| News
Mintz Chairman R. Robert Popeo, 85, Remembered As 'Creative Strategist'
July 3, 2023| News
Energy & Sustainability Washington Update — July 2023
July 3, 2023| Blog| Viewpoint
It’s June 30th – Time to Evaluate Your SEC Filer Status
June 30, 2023| Alert| Viewpoint
Message In A Bottle: Impact Of ‘Jack Daniel’s’ Trademark Ruling Debated
June 30, 2023| News
Telephone and Texting Compliance News: Third Circuit Affirms $286,000 Fraud Counterclaim Arbitration Award
June 30, 2023| Article| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.